JPMorgan Chase & Co’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-503
| Closed | -$375 | – | 6672 |
|
|
2024
Q4 | $375 | Hold |
503
| – | – | ﹤0.01% | 5780 |
|
|
2024
Q3 | $614 | Sell |
503
-1
| -0.2% | -$1 | ﹤0.01% | 5711 |
|
|
2024
Q2 | $1.04K | Sell |
504
-9,594
| -95% | -$19.9K | ﹤0.01% | 5589 |
|
|
2024
Q1 | $36.9K | Sell |
10,098
-5,699
| -36% | -$20.8K | ﹤0.01% | 5067 |
|
|
2023
Q4 | $47.5K | Sell |
15,797
-10,305
| -39% | -$31K | ﹤0.01% | 5025 |
|
|
2023
Q3 | $56.1K | Buy |
26,102
+4,779
| +22% | +$10.3K | ﹤0.01% | 4865 |
|
|
2023
Q2 | $119K | Buy |
21,323
+19,639
| +1,166% | +$110K | ﹤0.01% | 4558 |
|
|
2023
Q1 | $10K | Buy |
1,684
+128
| +8% | +$760 | ﹤0.01% | 5276 |
|
|
2022
Q4 | $9K | Sell |
1,556
-1,224
| -44% | -$7.08K | ﹤0.01% | 5132 |
|
|
2022
Q3 | $15K | Buy |
2,780
+877
| +46% | +$4.73K | ﹤0.01% | 4994 |
|
|
2022
Q2 | $7K | Sell |
1,903
-16,327
| -90% | -$60.1K | ﹤0.01% | 5251 |
|
|
2022
Q1 | $113K | Buy |
18,230
+9,243
| +103% | +$57.3K | ﹤0.01% | 4691 |
|
|
2021
Q4 | $102K | Buy |
8,987
+6,155
| +217% | +$69.9K | ﹤0.01% | 4818 |
|
|
2021
Q3 | $53K | Buy |
+2,832
| New | +$53K | ﹤0.01% | 4945 |
|